reports
VERASTEM sees its rating upgraded to Neutral despite the loss of a fun...
The independent financial analyst theScreener just upgraded the general evaluation of VERASTEM (US), active in the Biotechnology industry. As regards its fundamental valuation, the title loses a star(s) and now shows 2 out of 4 stars. Its market behaviour, however, remains stable and can be qualified as risky. theScreener believes that the loss of a star(s) does not preclude an overall rating upgrade to Neutral. As of the analysis date March 22, 2022, the closing price was USD 1.30 and its expec...
Verastem Inc: 1 director bought
A director at Verastem Inc bought 50,000 shares at 2.170USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- MarketLine Department
Oncomed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partners...
Summary Marketline's Oncomed Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Oncomed Pharmaceuticals, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive br...
- Jonathan Moreland
XNCR XENCOR INC.
WSBC WESBANCO INC.
VSTM VERASTEM INC
SYNL SYNALLOY CORP.
RYI RYERSON HOLDING CORPORATION
PLUG PLUG POWER INC.
OPK OPKO HEALTH INC.
OCUL OCULAR THERAPEUTIX
MHLD MAIDEN HOLDINGS LTD.
MG MISTRAS GROUP
LGND LIGAND PHARMACEUTICALS INCORPORATED
LAND GLADSTONE LAND CORP.
III INFORMATION SERVICES GROUP INC.
HIIQ HEALTH INSURANCE INNOVATIONS INC
GSAT GLOBALSTAR INC.
GABC GERMAN AMERICAN BANCORP
DRAD DIGIRAD CORP.
DNR DENBURY RESOURCES INC.
BSRR SIERRA BANCORP
AXO ABRAXAS PETROLEUM CORP.
ATSG AIR TRANSPORT SERVICES GROUP INC.
NEWT NEWTEK BUSINESS SERVICES INC.
OASPQ OASIS PETROLEUM INC.
GRBK GREEN BRICK PARTNERS
KFS KINGSWAY FINANCIAL SERVICES
KNDI KANDI TECHNOLGIES GROUP (N SHARES)
CECE CECO ENVIRONMENTAL CORP.
ISTR INVESTAR HOLD
KMI KINDER MORGAN INC CLASS P
TST THESTREET
INFU INFUSYSTEMS HOLDINGS INC.
OSG OVERSEAS SHIPHOLDING GROUP
CWH CAMPING WORLD HOLDINGS INC. CLASS A
INSG INSEEGO CORP
FRTA FORTERRA INC.
TVTY TIVITY HEALTH INC.
CADE CADENCE BANCORPORATION
WOW WIDEOPENWEST INC.
CMP COMPA SA
MBIN MERCHANTS BANCORP
WGO WINNEBAGO INDUSTRIES INC.
KRMD REPRO MED SYSTEMS
CRDA CRAWFORD & COMPANY
MYOS ATLAS THERAPEUTICS CORP
WSC WILLSCOT MOBILE MINI HOLDINGS CORP. CLASS A
ARPO AERPIO PHARMACEUTICALS
ASRT INC.
NHS ASSERTIO HOLDINGS INC.
MNE NEUBERGER BERMAN HIGH YIELD ST
ETRN BLACKROCK MUNI NEW YORK INTERMEDIATE DURATION FUND
JWA EQUITRANS MIDSTREAM CORP
JOHN WILEY & SONS
INC.
- Jonathan Moreland
WSBC WESBANCO INC.
WDC WESTERN DIGITAL CORPORATION
VSTM VERASTEM INC
TNAV TELENAV
SYNL SYNALLOY CORP.
STON STONEMOR INC.
SATS ECHOSTAR CORPORATION CLASS A
PLUG PLUG POWER INC.
OPK OPKO HEALTH INC.
OCUL OCULAR THERAPEUTIX
MG MISTRAS GROUP
LAND GLADSTONE LAND CORP.
KR KROGER CO.
III INFORMATION SERVICES GROUP INC.
HIIQ HEALTH INSURANCE INNOVATIONS INC
GABC GERMAN AMERICAN BANCORP
EVH EVOLENT HEALTH INC CLASS A
EQT EQT CORPORATION
DRAD DIGIRAD CORP.
DFRG DEL FRISCO'S RESTAURANT GROUP
CORT CORCEPT THERAPEUTICS INCORPORATED.
BGCP BGC PARTNERS INC. CLASS A
AXSM AXSOME THERAPEUTICS
AXO ABRAXAS PETROLEUM CORP.
ATSG AIR TRANSPORT SERVICES GROUP INC.
ALG ALAMO GROUP INC.
NEWT NEWTEK BUSINESS SERVICES INC.
ISTR INVESTAR HOLD
TRUE TRUECAR INC.
TST THESTREET
SITE SITEONE LANDSCAPE SUPPLY INC.
RILY B RILEY SECURITIES INC
INFU INFUSYSTEMS HOLDINGS INC.
OTEL OTELCO INC
CNBKA CENTURY BANCORP INC. CL A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
IDSY I.D. SYSTEMS INC.
FRTA FORTERRA INC.
ADMP ADAMIS PHARMACEUTICALS CORP
TVTY TIVITY HEALTH INC.
SNAP SNAP INC. CLASS A
KEGX KEY ENERGY SVCS
CADE CADENCE BANCORPORATION
FEIM FREQUENCY ELECTRONICS INC.
WOW WIDEOPENWEST INC.
KRMD REPRO MED SYSTEMS
SFIX STITCH FIX CLASS A
FF FIRST MINING GOLD
CRDA CRAWFORD & COMPANY
WSC WILLSCOT MOBILE MINI HOLDINGS CORP. CLASS A
ASRT ASSERTIO HOLDINGS INC.
NHS NEUBERGER BERMAN HIGH YIELD ST
FSK FS KKR CAPITAL CORP
MNE BLACKROCK MUNI NEW YORK INTERMEDIATE DURATION FUND
- Jonathan Moreland
VSTM VERASTEM INC
SATS ECHOSTAR CORPORATION CLASS A
OPK OPKO HEALTH INC.
ATSG AIR TRANSPORT SERVICES GROUP INC.
TRUE TRUECAR INC.
INFU INFUSYSTEMS HOLDINGS INC.
CADE CADENCE BANCORPORATION
FEIM FREQUENCY ELECTRONICS INC.
WOW WIDEOPENWEST INC.
SFIX STITCH FIX CLASS A
CRDA CRAWFORD & COMPANY
NHS NEUBERGER BERMAN HIGH YIELD ST
MNE BLACKROCK MUNI NEW YORK INTERMEDIATE DURATION FUND
- Jonathan Moreland
WIRE ENCORE WIRE CORPORATION
VSTM VERASTEM INC
TSLA TESLA INC
TRCB TWO RIVER BANCORP
TCBI TEXAS CAPITAL BANCSHARES INC.
T AT&T INC.
SNV SYNOVUS FINANCIAL CORP.
PACW PACWEST BANCORP
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
HOMB HOME BANCSHARES INC.
HBI HANESBRANDS INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
FLT FLEETCOR TECHNOLOGIES INC.
FIT FITBIT INC. CLASS A
FAST FASTENAL COMPANY
EBSB MERIDIAN BANCORP INC
BOCH BANK OF COMMERCE HOLDINGS
BDGE BRIDGE BANCORP INC.
AZZ AZZ INC.
ACOR ACORDA THERAPEUTICS INC.
MLVF MALVERN BANCORP
JMP JMP GROUP LLC
FNB F.N.B. CORPORATION
CMO CAPSTEAD MORTGAGE CORPORATION
TSC TRISTATE CAPITAL HOLDINGS INC
UNFI UNITED NATURAL FOODS INC.
MLI MUELLER INDUSTRIES INC.
AIRT AIR T INC.
FSBW FS BANCORP INC
AVK ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
ODT ODONATE THERAPEUTICS INC
ROSE ROSEHILL RESOURCES
KRYS KRYSTAL BIOTECH INC
SFS SANTA FE SNYDER CORP
MMAC MMA CAPITAL MANAGEMENT
GMS LLC
BBDC GMS INC.
FPAY BARINGS BDC INC.
SLCA FLEXSHOPPER
PLAG U.S. SILICA HOLDINGS
INC.
PLANET GREEN HOLDINGS (N SHARES)
- Jonathan Moreland
WIRE ENCORE WIRE CORPORATION
VSTM VERASTEM INC
TCBI TEXAS CAPITAL BANCSHARES INC.
SPKE SPARK ENERGY INC-CLASS A
PSA PUBLIC STORAGE
PRGX PRGX GLOBAL
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
KMPH KEMPHARM INC
58I1 INTREPID POTASH INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HY HYSTER-YALE MATERIALS HANDLING INC. CLASS A
HBI HANESBRANDS INC.
FRED FRED'S INC.
FLKS FLEX PHARMA INC
FLDM FLUIDIGM
FDX FEDEX CORPORATION
FATE FATE THERAPEUTICS INC
FAST FASTENAL COMPANY
DLTR DOLLAR TREE INC.
CRMD CORMEDIX INC.
BDGE BRIDGE BANCORP INC.
GNK GENCO SHIPPING & TRADING LTD.
MLVF MALVERN BANCORP
JMP JMP GROUP LLC
BSET BASSETT FURNITURE INDUSTRIES INC.
CERC CERECOR INC
DSPG DSP GROUP INC.
FBHS
ITI FORTUNE BRANDS HOME & SECURITY INC.
THO ITERIS
ARDC THOR INDUSTRIES INC.
AIRT ARES DYNAMIC CREDIT ALLOCATION
FSBW AIR T INC.
CNBKA FS BANCORP INC
NOVN CENTURY BANCORP INC. CL A
ASPU NOVAN INC
MEET ASPEN GROUP INC
RGRX MEET GROUP
FEIM REGENERX BIOPHARMACEUTICALS INC
KALA FREQUENCY ELECTRONICS INC.
ATNX KALA PHARMACEUTICALS INC.
APPN ATHENEX
ROSE APPIAN
MMAC ROSEHILL RESOURCES
MTEM MMA CAPITAL MANAGEMENT
BBDC LLC
FPAY VOIP INC.
SLCA BARINGS BDC INC.
FUND FLEXSHOPPER
PDI U.S. SILICA HOLDINGS
PCI INC.
AMRK ROYCE FOCUS TRUST
PLAG INC.
PIMCO DYNAMIC INCOME FUND
PIMCO DYNAMIC CREDIT INCOME FUND
A-MARK PRECIOUS METALS
INC.
PLANET GREEN HOLDINGS (N SHARES)
- Jonathan Moreland
SYNA SYNAPTICS INCORPORATED
WIRE ENCORE WIRE CORPORATION
VSTM VERASTEM INC
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
SPKE SPARK ENERGY INC-CLASS A
PRGX PRGX GLOBAL
NGL NGL ENERGY PARTNERS LP
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
LTRX LANTRONIX INC.
KMPH KEMPHARM INC
FLDM FLUIDIGM
FATE FATE THERAPEUTICS INC
DLTR DOLLAR TREE INC.
CRS CARPENTER TECHNOLOGY CORPORATION
ACOR ACORDA THERAPEUTICS INC.
ACAD ACADIA PHARMACEUTICALS INC.
MLVF MALVERN BANCORP
JMP JMP GROUP LLC
IRIX IRIDEX CORP.
TTNP TITAN PHARMACEUTICALS INC.
CERC CERECOR INC
DSPG DSP GROUP INC.
FBHS
NSA FORTUNE BRANDS HOME & SECURITY INC.
PAGP NATIONAL STORAGE AFFILIATES TRUST
THO PLAINS GP HOLDINGS LP CLASS A
UNVR THOR INDUSTRIES INC.
ARDC UNIVAR SOLUTIONS INC.
AIRT ARES DYNAMIC CREDIT ALLOCATION
CNBKA AIR T INC.
NOVN CENTURY BANCORP INC. CL A
ASPU NOVAN INC
EDGW ASPEN GROUP INC
MEET EDGEWATER TECHNOLOGY INC.
RGRX MEET GROUP
FEIM REGENERX BIOPHARMACEUTICALS INC
KALA FREQUENCY ELECTRONICS INC.
ETP KALA PHARMACEUTICALS INC.
APPN ENERGY TRANSFER PARTNERS
APLS L.P.
ROSE APPIAN
SSP APELLIS PHARMACEUTICALS
EOLS ROSEHILL RESOURCES
LIFE THE E.W. SCRIPPS COMPANY
MMAC EVOLUS INC
OGEN LIFE TECHNOLOGIES CORPORATION
MTEM MMA CAPITAL MANAGEMENT
BBDC LLC
FPAY ORAGENICS INC.
SLCA VOIP INC.
FUND BARINGS BDC INC.
FLEXSHOPPER
U.S. SILICA HOLDINGS
INC.
ROYCE FOCUS TRUST
INC.
- Jonathan Moreland
WIRE ENCORE WIRE CORPORATION
VSTM VERASTEM INC
SPKE SPARK ENERGY INC-CLASS A
RUN SUNRUN INC.
PRGX PRGX GLOBAL
LEN LENNAR CORPORATION CLASS A
HY HYSTER-YALE MATERIALS HANDLING INC. CLASS A
GTT GTT COMMUNICATIONS INC.
FOLD AMICUS THERAPEUTICS INC.
FB FACEBOOK INC. CLASS A
EBSB MERIDIAN BANCORP INC
ACOR ACORDA THERAPEUTICS INC.
AIRT AIR T INC.
AVK ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
NOVN NOVAN INC
SNAP SNAP INC. CLASS A
KALA KALA PHARMACEUTICALS INC.
APPN APPIAN
ODT ODONATE THERAPEUTICS INC
ROSE ROSEHILL RESOURCES
SSP THE E.W. SCRIPPS COMPANY
MMAC MMA CAPITAL MANAGEMENT
BBDC LLC
FPAY BARINGS BDC INC.
SLCA FLEXSHOPPER
FUND U.S. SILICA HOLDINGS
INC.
ROYCE FOCUS TRUST
INC.
- Jonathan Moreland
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rul...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (Nasdaq: VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant of stock options to ten new employees to purchase an aggregate of 209,000 shares of Verastem Oncology’s common stock. The options were granted as an inducement material to the employees’ acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to $4.19, the clos...
Verastem Oncology Reports First Quarter 2018 Financial Results
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today reported financial results for the quarter ended March 31, 2018 and provided an overview of certain corporate developments. “We’ve had a strong start to 2018, highlighted foremost by the acceptance of our duvelisib New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA), including the receipt of Priorit...
Verastem Oncology Reports on Chronic Lymphocytic Leukemia/Small Lympho...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, yesterday hosted in New York City an Analyst and Investor Day, titled, “Duvelisib: Harnessing the Power of Dual PI3K Inhibition.” The program featured key opinion leaders in the hematologic oncology field: Jennifer Brown, MD, PhD, Associate Professor of Medicine, Harvard Medical School Director, and Director, CLL Center of the...
Verastem to Host Analyst and Investor Day on May 2, 2018
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced that it will host an Analyst and Investor Day titled, “Duvelisib: Harnessing the Power of Dual PI3K Inhibition,” on Wednesday, May 2, 2018 from 10:30 am – 1:00 pm ET in New York City. The agenda will include an in-depth discussion of the Company’s lead oral oncology candidate, duvelisib, including the unmet need of patients, where phosphoinosit...
Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (Nasdaq:VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant of stock options to six new employees to purchase an aggregate of 364,000 shares of Verastem’s common stock. The options were granted as an inducement material to the employees’ acceptance of employment with Verastem in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to $2.88, the closing price of Verast...
FDA Accepts New Drug Application for Duvelisib and Grants Priority Rev...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ:VSTM), a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its New Drug Application (NDA) for its lead product candidate duvelisib. Duvelisib is a first-in-class oral dual inhibitor of phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma, for which Verastem is seeking full approval for t...
Verastem to Present at the H.C. Wainwright Global Life Sciences Confer...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced that the Company will present at the H.C. Wainwright Global Life Sciences Conference on Monday, April 9, 2018 at 11:05 am CEST in Monte Carlo, Monaco. A live webcast of the presentation will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 90 days. ...
Verastem Updates Presentation Time for Oppenheimer & Co. Healthcare Co...
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ:VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced that the Company will present at the 28th Annual Oppenheimer & Co. Healthcare Conference on Tuesday, March 20, 2018 at 8:00am in New York City, NY, USA. Verastem’s presentation was originally scheduled for 11:30am but was subsequently moved to 8:00am. A live webcast of the presentation will be available on the investors section of the Company’s ...
Verastem to Present at Upcoming Conferences
BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ:VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced that the Company will present at the following investor conferences: The 28th Annual Oppenheimer & Co. Healthcare Conference on Tuesday, March 20, 2018 at 11:30am in New York City, NY, USA. The 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 at 5:00pm in New York City, NY, USA. ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.